Pages that link to "Item:Q1716254"

The following pages link to Development of a mathematical model that predicts the outcome of hormone therapy for prostate cancer (Q1716254):

Displaying 32 items.

• A partial differential equation model and its reduction to an ordinary differential equation model for prostate tumor growth under intermittent hormone therapy (Q464772) (← links)
• A stochastic model of cancer growth subject to an intermittent treatment with combined effects: reduction in tumor size and rise in growth rate (Q486640) (← links)
• Mathematical modeling of continuous and intermittent androgen suppression for the treatment of advanced prostate cancer (Q504676) (← links)
• Global dynamics of a model of joint hormone treatment with dendritic cell vaccine for prostate cancer (Q524063) (← links)
• Ability of intermittent androgen suppression to selectively create a non-trivial periodic orbit for a type of prostate cancer patients (Q739736) (← links)
• Estimating a non-homogeneous Gompertz process with jumps as model of tumor dynamics (Q1658473) (← links)
• The dose-dense principle in chemotherapy (Q1705272) (← links)
• Parameter identification of a model for prostate cancer treated by intermittent therapy (Q1716890) (← links)
• A stochastic approach to risk management for prostate cancer patients on active surveillance (Q1786034) (← links)
• Halting the hallmarks: a cellular automaton model of early cancer growth inhibition (Q2003442) (← links)
• Intermittent hormone therapy models analysis and Bayesian model comparison for prostate cancer (Q2060027) (← links)
• Do mechanisms matter? Comparing cancer treatment strategies across mathematical models and outcome objectives (Q2092087) (← links)
• On tumoural growth and treatment under cellular dedifferentiation (Q2105497) (← links)
• Global analysis of the dynamics of a piecewise linear vector field model for prostate cancer treatment (Q2120308) (← links)
• Dynamics and implications of models for intermittent androgen suppression therapy (Q2160560) (← links)
• Predictability and identifiability assessment of models for prostate cancer under androgen suppression therapy (Q2160715) (← links)
• Analysis of mathematical model of prostate cancer with androgen deprivation therapy (Q2206055) (← links)
• A time scales approach for modeling intermittent hormone therapy for prostate cancer (Q2211777) (← links)
• Practically scheduling hormone therapy for prostate cancer using a mathematical model (Q2317045) (← links)
• The parameter Houlihan: a solution to high-throughput identifiability indeterminacy for brutally ill-posed problems (Q2328494) (← links)
• Optimal design of personalized prostate cancer therapy using infinitesimal perturbation analysis (Q2406966) (← links)
• Estimating and determining the effect of a therapy on tumor dynamics by means of a modified Gompertz diffusion process (Q2413917) (← links)
• Comparison between mathematical models of intermittent androgen suppression for prostate cancer (Q2415738) (← links)
• Nonlinear system identification for prostate cancer and optimality of intermittent androgen suppression therapy (Q2435994) (← links)
• Avoiding healthy cells extinction in a cancer model (Q2632759) (← links)
• A new protocol for intermittent androgen suppression therapy of prostate cancer with unstable saddle-point dynamics (Q2632781) (← links)
• Modeling the synergistic properties of drugs in hormonal treatment for prostate cancer (Q2659871) (← links)
• Parameter estimation and optimal scheduling algorithm for a mathematical model of intermittent androgen suppression therapy for prostate cancer (Q2787900) (← links)
• The Impact of Fractional Differentiation in Terms of Fitting for a Prostate Cancer Model Under Intermittent Androgen Suppression Therapy (Q4992720) (← links)
• Achieving precise mechanical control in intrinsically noisy systems (Q5141505) (← links)
• Optimization therapy by coupling intermittent androgen suppression with impulsive chemotherapy for a prostate cancer model (Q6066157) (← links)
• Selection of prostate cancer therapy strategy under early androgen suppression treatment (Q6199715) (← links)